Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUY922 + Trastuzumab in HER2+ Advanced Gastric Cancer
NCT01402401Phase 2Terminated
- Sponsor
- Novartis
- Start
- Nov 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of Luminespib in gastric cancer (GC), sponsored by Novartis. Started Nov 2011; status: terminated.
02
Drugs
Luminespib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01402401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402401.